{"nct_id":"NCT02924688","title":"A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma","status":"COMPLETED","status_verified_date":"2021-02","start_date":"2016-10-13","start_date_type":"ACTUAL","primary_completion_date":"2019-02-22","primary_completion_date_type":"ACTUAL","completion_date":"2019-02-22","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}